anifrolumab
ItalyDrugs containing this active substance
-
Saphnelo is used for the treatment of moderate to severe lupus (systemic lupus erythematosus, SLE) in adults, when the disease is not well controlled with standard therapies.
Form: solution for infusion, concentrate
Active substance Dosage anifrolumab - ATC: L04AG11
Manufacturer: ASTRAZENECA AB